These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 234638)

  • 1. Cancer procoagulant A: a factor X activating procoagulant from malignant tissue.
    Gordon SG; Franks JJ; Lewis B
    Thromb Res; 1975 Feb; 6(2):127-37. PubMed ID: 234638
    [No Abstract]   [Full Text] [Related]  

  • 2. The normal coagulation mechanism.
    Bennett B; Ratnoff OD
    Med Clin North Am; 1972 Jan; 56(1):95-104. PubMed ID: 4550195
    [No Abstract]   [Full Text] [Related]  

  • 3. The mechanism of blood coagulation.
    Owren PA; Stormorken H
    Ergeb Physiol; 1973; 68():1-53. PubMed ID: 4593726
    [No Abstract]   [Full Text] [Related]  

  • 4. Changes in coagulation factors after hepatic artery ligation in dogs.
    Bengmark S; Hafström LO; Korsan-Bengtsen K; Loughridge B
    Acta Hepatosplenol; 1970; 17(6):398-402. PubMed ID: 5212541
    [No Abstract]   [Full Text] [Related]  

  • 5. Procoagulant activity in bronchoalveolar lavage in the adult respiratory distress syndrome. Contribution of tissue factor associated with factor VII.
    Idell S; Gonzalez K; Bradford H; MacArthur CK; Fein AM; Maunder RJ; Garcia JG; Griffith DE; Weiland J; Martin TR
    Am Rev Respir Dis; 1987 Dec; 136(6):1466-74. PubMed ID: 3688650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The activation of factor IX by the tissue factor pathway.
    Rapaport SI
    Prog Clin Biol Res; 1981; 72():57-76. PubMed ID: 7335650
    [No Abstract]   [Full Text] [Related]  

  • 7. [Disseminated intravascular coagulation].
    Amir J
    Harefuah; 1972 Jul; 83(1):29-32. PubMed ID: 4264530
    [No Abstract]   [Full Text] [Related]  

  • 8. Membrane-bound enzyme complexes in blood coagulation.
    Mann KG
    Prog Hemost Thromb; 1984; 7():1-23. PubMed ID: 6099581
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of factor VII in the intrinsic pathway: a brief review.
    Prydz H
    Haemostasis; 1983; 13(3):156-60. PubMed ID: 6350120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation pathways of the coagulation system in normal haemostasis.
    Osterud B
    Scand J Haematol; 1984 Apr; 32(4):337-45. PubMed ID: 6372076
    [No Abstract]   [Full Text] [Related]  

  • 11. A peptide sequence from the EGF-2 like domain of FVII inhibits TF-dependent FX activation.
    Orning L; Stephens RW; Petersen LB; Hamers MJ; Stormorken H; Sakariassen KS
    Thromb Res; 1997 Apr; 86(1):57-67. PubMed ID: 9172287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage procoagulants.
    Edwards RL; Rickles FR
    Prog Hemost Thromb; 1984; 7():183-209. PubMed ID: 6397766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for an essential role of tissue factor dependent blood coagulation in the pathogenesis of the local Shwartzman reaction.
    Zivelin A; Rao LV; Rapaport SI
    Blood Cells Mol Dis; 1995; 21(1):9-19. PubMed ID: 7655863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the initiation of coagulation by factor VII.
    Nemerson Y
    Haemostasis; 1983; 13(3):150-5. PubMed ID: 6350119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TISSUE EXTRACTS AND THEIR SENSITIVITY TO FACTOR VII AND FACTOR X.
    DENSON KW
    Thromb Diath Haemorrh; 1964 Apr; 11():146-54. PubMed ID: 14171582
    [No Abstract]   [Full Text] [Related]  

  • 16. [The different action of bovine and human factor VIII (anti-haemophilic globulin) on factor X consumption during coagulation].
    Mayer G; Mayer S; Waitz R
    Rev Fr Etud Clin Biol; 1969 Dec; 14(10):1028-31. PubMed ID: 5377890
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of tissue factor pathway inhibitor in a revised coagulation cascade.
    Broze GJ
    Semin Hematol; 1992 Jul; 29(3):159-69. PubMed ID: 1641662
    [No Abstract]   [Full Text] [Related]  

  • 18. The dual role of factor VII in blood coagulation. Initiation and inhibition of a proteolytic system by a zymogen.
    Zur M; Radcliffe RD; Oberdick J; Nemerson Y
    J Biol Chem; 1982 May; 257(10):5623-31. PubMed ID: 6978336
    [No Abstract]   [Full Text] [Related]  

  • 19. The thrombogenicity of prothrombin complex concentrates: I. The relationship between in vitro characteristics and in vivo thrombogenicity in rabbits.
    Giles AR; Johnston M; Hoogendoorn H; Blajchman M; Hirsh J
    Thromb Res; 1980 Feb 1-15; 17(3-4):353-66. PubMed ID: 6768160
    [No Abstract]   [Full Text] [Related]  

  • 20. Compound 48/80 suppresses monocytic tissue factor-initiated extrinsic blood coagulation induced by bacterial endotoxin.
    Chu AJ; Raphael UO; Prasad JK; Beydoun S; Ramos N
    J Surg Res; 1999 Dec; 87(2):252-7. PubMed ID: 10600357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.